Taking Benefit of Economies of Scale in Producing Vaccine in Natural Setup of Human Body: Coronavirus Pandemic

Vrajlal Sapovadia

MPRA Paper from University Library of Munich, Germany

Abstract: This article is an attempt to provide lead for mass production of coronavirus vaccine (if the vaccines are produced by any research laboratories, clinically successful and approved by regulatory body like FDA) naturally. The unprecedented and unique spread of coronavirus has devastated the whole world and its economy. Scientists, research laboratories and governments are working hard to develop vaccine to combat the deadly disease. Once a reliable vaccine is produced, the next challenge will be to produce in large quantity and supply feasible dose units of vaccine across the globe. Based on primary understanding, we want to provide a lead, if human body can be used to produce further dose of vaccine, if artificially vaccine is injected to a person, his body may have capacity to produce transferable antigens to another human. Thus, a person who received first injection of vaccine will develop in his body the germs like normal infection minus its potency. The vaccination is controlled infection. His body will have gems like virus or bacteria, which can be used as subsequent dose to other person. His blood, plasma or otherwise can be transmitted to another person like artificially vaccination. Thus vaccinated person become the donor and this could be replicated to certain extent. This experiment also required theoretical study and assessment or evaluation of the result; i.e. practical aspects of possibility of production of antibody, its transferability, feasibility, safety, potency of antigens and immunity developed in the recipient. The process may be different for different virus and vaccines.

Keywords: Coronavirus; Pandemic; Vaccine; Virus; Human Body as production unit (search for similar items in EconPapers)
JEL-codes: I0 I00 I23 (search for similar items in EconPapers)
Date: 2020-03-30
New Economics Papers: this item is included in nep-ore
References: Add references at CitEc
Citations:

Downloads: (external link)
https://mpra.ub.uni-muenchen.de/99371/1/MPRA_paper_99371.pdf original version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pra:mprapa:99371

Access Statistics for this paper

More papers in MPRA Paper from University Library of Munich, Germany Ludwigstraße 33, D-80539 Munich, Germany. Contact information at EDIRC.
Bibliographic data for series maintained by Joachim Winter ().